Tetra Bio Pharma Inc (TBP.CA) Forecast, Price Target & Analyst Ratings
TSX:TBP • CA88166Y1007
Current stock price
0.025 CAD
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Tetra Bio Pharma Inc (TBP.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.00
Upside
-100.00%
From current price of CA$0.03 to mean target of CA$0.00, Based on 5 analyst forecasts
Low
CA$0.00
Median
CA$0.00
High
CA$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
TBP.CA was analyzed by 5 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TBP.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed TBP.CA. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||||
| EBITDA YoY % growth | N/A | N/A | -6.22M | -11.45M -84.08% | -12.83M -12.05% | -20.33M -58.46% | -24.183M -18.95% | |
| EBIT YoY % growth | -630K | -1.04M -65.08% | -6.23M -499.04% | -11.46M -83.95% | -12.86M -12.22% | -20.36M -58.32% | -24.295M -19.33% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A